Summary by Moomoo AI
Sinda Biopharmaceuticals Limited (“Sinda Biologics”) issued a Clarification Notice on April 3, 2024, correcting errors in its announcement issued on March 24, 2024 regarding the granting of restricted shares to unrelated employees. The allocation ratio of restricted shares referred to in the original announcement is incorrect. The correct proportion should be 75% of the shares will be attributed on March 22, 2027, and the remaining 25% will be attributed on March 22, 2028. THIS CLARIFICATION ANNOUNCEMENT INDICATES THAT ONE-THIRD OF THE ANNUAL SHARE ATTRIBUTION DESCRIBED IN THE PRIOR ANNOUNCEMENT WAS DUE TO A CLERICAL ERROR. Other information in the original announcement remains unchanged, except for corrections to the attribution period.